Glenn Goddard Exercises Options at Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 03, 2024

SEC Form 4 · No Market Transaction

Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner

Glenn Goddard

CFO

TXN 2024-01-01 · FILED 2024-01-03

Equity Position 46K sh 42,888 → 45,950

Equity Change +7.1% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
Glenn Goddard CIK 0001581992	CFO

Glenn Goddard at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2024-01-01	M - Exercise	3,062 A		—	45,950	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitF1 F2		2024-01-01	M - Exercise	3,062 D	$0.00	2031-03-02	3,062 Common Stock	Direct

Footnotes (2)

F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Show more
F2: On March 3, 2021, the reporting person was granted 12,250 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Intellia Therapeutics Inc

GET /v1/forms/4/0000950170-24-001173 API docs